Key Financial Data Of Reporting Company

Cyfuse Biomedical K.K. - Filing #7567836

Concept 2023-01-01 to
2023-03-31
As at
2023-03-31
As at
2022-12-31
2022-01-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
7,070,000 JPY
374,477,000 JPY
Ordinary profit (loss)
-167,047,000 JPY
-433,165,000 JPY
Profit (loss)
-168,089,000 JPY
-473,962,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
Share capital
1,273,915,000 JPY
1,272,005,000 JPY
Total number of issued shares
7,803,300 xbrli:shares
7,773,300 xbrli:shares
Net assets
3,605,531,000 JPY
3,769,801,000 JPY
Total assets
4,594,521,000 JPY
4,815,337,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-21.56
-177.67
Diluted earnings per share
Equity-to-asset ratio
0.785 xbrli:pure
0.783 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.